Best Alzheimer's and Dementia Research Grants in New Hampshire

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

New Hampshire nonprofit AFA member organizations running Alzheimer’s or dementia programs can access funding through the Alzheimer’s Foundation of America to support services and education. Grants of US $6,000, awarded twice yearly, may cover administrative costs, staff salaries and training, occupancy, and necessary supplies or equipment for new or existing programs.

Research institutions and universities in New Hampshire can access funding to provide intensive postbaccalaureate research education in Alzheimer’s disease and Alzheimer’s disease-related dementias, including up to US $400,000 for program support. The National Institutes of Health backs one-to-two-year mentored research experiences that prepare recent graduates for advanced degrees and research careers in aging and dementia.

Educational and research institutions running Alzheimer’s and dementia-focused summer research education programs in New Hampshire can apply for up to US $200,000 to support hands-on AD/ADRD projects for high school students, undergraduates, or science teachers. With a mission to expand the AD/ADRD research workforce, the National Institutes of Health backs programs combining lab experience with structured STEM enrichment.

New Hampshire Alzheimer’s and dementia researchers at early-career, assistant-professor level (≤7 years) can access funding through the Alzheimer’s Association to launch preliminary or pilot studies. Awards of US $70,000 - US $200,000 support basic, translational, clinical, psychosocial, neuroimaging, epidemiology, care intervention, biomarker, therapeutic target, and health equity research, with U.S. and international eligibility.

New Hampshire 501(c)(3) nonprofits supporting older adults with dementia and brain degenerative diseases can access funding through the Sephardic Home For The Aged Foundation to improve care and quality of life. Eligible organizations have operated at least two years and may propose innovative aging-related programs; an LOI is required before a full application.

Postdoctoral researchers conducting Alzheimer’s and dementia research in New Hampshire can seek funding for early-career projects, with awards up to US $200,000. The Alzheimer’s Association supports dementia and Alzheimer’s disease research by nurturing investigators from diverse backgrounds as they transition toward independent, mentored research careers in this field.

Clinician scientists conducting dementia and Alzheimer’s research, including those in New Hampshire, can access funding for training and career development through this fellowship program. Grants from Alzheimer’s Association help licensed, practicing clinicians deepen research skills in areas such as neurology, psychiatry, geriatrics, psychology, neuropathology, or radiology, with awards up to US $250,000 and encouragement for applicants from underrepresented groups.

With a mission to support individuals and families affected by dementia, Alzheimer’s Foundation of America provides New Hampshire Alzheimer’s and dementia organizations with the Anne & Irving Brodsky Innovation Grant. Eligible AFA nonprofit member organizations nationwide can apply for US $25,000 to fund innovative programs, including administrative costs, staff training, salaries, occupancy, supplies, and equipment.

Public safety agencies running dementia wandering-prevention or related safety programs in New Hampshire can apply for support covering administrative costs, staff training, equipment, and community outreach. Focused on dementia and Alzheimer’s disease, the Alzheimer’s Foundation of America invites eligible Project Lifesaver International member agencies to seek US $6,000 grants, awarded twice yearly, for these initiatives.

Nonprofit organizations providing dementia and Alzheimer’s respite care services in New Hampshire can apply for the Milton & Phyllis Berg Family Respite Care Grants from the Alzheimer’s Foundation of America; awards are US $6,000 to support respite care scholarships. Funding may cover supplies, equipment, capacity building, administrative costs, and staff training.

Grants supporting biomedical imaging research in Alzheimer’s and other neurodegenerative diseases are available to eligible research organizations, with awards of US $200,000 for one-year pilot projects. Grants from Alzheimer’s Association help New Hampshire Alzheimer’s and dementia researchers develop novel imaging tools and innovative imaging data analysis approaches, within a broader U.S. funding program.

Researchers studying aging, Alzheimer’s disease, or related dementias in New Hampshire can explore this upcoming NIH opportunity supporting investigations into mechanisms linking olfactory decline with aging and AD/ADRD. Projects may use human or animal models and diverse methods, including cellular, molecular, imaging, physiological, omics, or other innovative approaches to identify disease mechanisms and therapeutic targets.

Focused on dementia and Alzheimer’s disease research, this upcoming NIH Notice of Funding Opportunity invites investigators to study cerebellar contributions to cognitive and affective functions in aging and AD/ADRD. Eligible researchers in New Hampshire and other U.S. jurisdictions may propose basic, animal, human, secondary data, or intervention-focused R01 projects.

Families needing in-home respite care for loved ones with Alzheimer’s or other dementias can apply for the Margaret B. Moeller Memorial Fund, awarding US $200 - US $3,000 to pay care companions or aides. New Hampshire dementia-focused organizations assisting such families may be able to help clients access this support.

New Hampshire Alzheimer’s and dementia researchers can access funding through the US Dept. of Health & Human Services: National Institutes of Health for preclinical validation and early-stage drug discovery. This upcoming U01 opportunity will support rigorous work on novel Alzheimer’s and related dementia targets, including small molecules, biologics, and emerging therapeutic modalities across eligible U.S. locations.

Research institutions forming interdisciplinary consortia to study neurodegeneration mechanisms in Alzheimer’s disease-related dementias, including New Hampshire-based teams, can apply for collaborative “Center without Walls” support. National Institutes of Health, via NINDS, anticipates funding networks that integrate advanced technologies, disease-relevant models, clinical science, and human specimens to uncover novel ADRD mechanisms, biomarkers, and therapeutic targets.

Research institutions studying how neural exposome factors influence Alzheimer’s disease-related dementias can apply for National Institutes of Health support, including projects based in New Hampshire. National Institutes of Health, via NINDS, funds mechanistic, translational, and human subjects research on environmental toxins, sleep, stress, and related pathways affecting ADRD pathology, progression, resilience, and disparities.

Research institutions and teams conducting Alzheimer’s and dementia studies in New Hampshire can apply for National Institutes of Health phased funding to functionally validate new therapeutic targets. This opportunity supports development of models, technologies, and cross-laboratory validation to de-risk translational research on Alzheimer’s disease-related dementias across the U.S. and territories.

Research institutions and eligible organizations studying dementia and Alzheimer’s care can apply for Alzheimer’s Association HSR-ADRD awards of up to US $250,000 to investigate detection, diagnosis, and post-diagnostic care. New Hampshire Alzheimer’s and dementia researchers may be eligible for projects on early detection value and care pathways across the dementia care continuum.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.

The National Institute on Aging (NIA) is inviting applications for the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional). This initiative seeks to support pre-clinical and early-stage clinical development of innovative drug candidates aimed at preventing Alzheimer's disease or treating its symptoms. The program encourages collaboration among researchers and aims to enhance the therapeutic pipeline for AD through targeted approaches. This notice allows potential applicants time to prepare robust projects.

The BJA FY 2026 Kevin and Avonte Program aims to reduce the injuries and fatalities of individuals with dementia and developmental disabilities who wander from safe environments. This funding opportunity supports law enforcement and public safety agencies in implementing locative technologies to track missing individuals and develop programs that enhance safety and facilitate rescues, ultimately ensuring the well-being of vulnerable populations.

The Alzheimer's Disease Programs Initiative (ADPI) aims to foster the development of dementia-capable community health worker programs within the National Aging Network. This initiative, supported by the US HHS: Administration for Community Living (ACL), seeks to enhance dementia screening, reduce barriers to care, and improve access to essential services for individuals with dementia and their caregivers. By integrating community health workers into aging services, the program aspires to elevate the quality of life for those affected.

Early-career Alzheimer’s and dementia researchers, including those based in New Hampshire, can apply for BrightFocus Foundation’s Alzheimer’s Disease Research Grants; awards range from US $200,000 - US $300,000 for pioneering lab-based or clinical studies. Eligible MD, PhD, and postdoctoral investigators pursue projects advancing understanding, prevention, or treatment of Alzheimer’s disease and related conditions.

The Barney Family Foundation Grant focuses on improving early education and advancing medical research, particularly in cancer and Alzheimer’s. It supports organizations that demonstrate a clear plan to enhance children's life experiences and educational opportunities for those in grades K-8. Grants typically range from $5,000 to $50,000, prioritizing established entities while welcoming startups. Eligible applicants must have 501(c)(3) status, and the Foundation does not fund individual requests or political activities.